Make Informed Investment Decisions with Affordable Access to Experts

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Exploring the market potential of Madrigal's MGL-3196 for the treatment of heterozygous Familial Hypercholesterolemia (HeFH)

Ticker(s): MDGL

Who's the expert?

Name: Dr Michael D. Shapiro - D.O.

Institution: Oregon Health & Science University

  • Associate Director of the Center for Preventive Cardiology and Professor at Oregon Health & Science University with a specific clinical focus on inherited lipid disorders.
  • Personally manages ~500 patients with HeFH within the center for Preventive Cardiology.
  • Research focuses on PCSK9 physiology and its impact on lipoprotein metabolism; engaged in clinical trials testing novel lipid modulating therapeutics.

Interview Questions
Q1.

Please describe your clinical practice; how many patients with HeFH do you currently manage?

Added By: c_admin
Q2.

What are your initial thoughts on the recent results from the Phase 2 HeFH trial of MGL-3196?

Added By: c_admin
Q3.

On a scale of 1-10 (10 being extremely excited), how would you rate your level of excitement for this drug?

Added By: c_admin
Q4.

Are there any other therapies in the HeFH space that look very promising to you right now?

Added By: c_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.